A rating of 92 puts Heron Therapeutics Inc (HRTX) near the top of the Biotechnology industry according to InvestorsObserver. Heron Therapeutics Inc's score of 92 means it scores higher than 92% of stocks in the industry. Heron Therapeutics Inc also received an overall rating of 78, putting it above 78% of all stocks. Biotechnology is ranked 18 out of the 148 industries.
HRTX has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on HRTX!
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.
What's Happening With Heron Therapeutics Inc Stock Today?
Heron Therapeutics Inc (HRTX) stock is trading at $3.03 as of 12:00 PM on Friday, Mar 15, a drop of -$0.02, or -0.66% from the previous closing price of $3.05. The stock has traded between $2.99 and $3.15 so far today. Volume today is light. So far 1,087,668 shares have traded compared to average volume of 2,616,414 shares.
Click Here to get the full Stock Report for Heron Therapeutics Inc stock.
Share this article:
Stay In The Know
Subscribe to our daily morning update newsletter and never miss out on the need-to-know market news, movements, and more.
Thank you for signing up! You're all set to receive the Morning Update newsletter
